Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | FAM177A1 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Fam177a (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of FAM177A mRNA | CTD | PMID:22206623 | FAM177A1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Fam177a (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FAM177A mRNA | CTD | PMID:28922406 | FAM177A1 | Human | 4,4'-sulfonyldiphenol | affects expression | ISO | Fam177a (Mus musculus) | 6480464 | bisphenol S affects the expression of FAM177A mRNA | CTD | PMID:30951980 | FAM177A1 | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Fam177a (Mus musculus) | 6480464 | [bisphenol S co-treated with LIF protein] results in decreased expression of FAM177A mRNA and [bisphenol S co-treated with Tretinoin] results in increased expression of FAM177A mRNA | CTD | PMID:30951980 | FAM177A1 | Human | all-trans-retinoic acid | multiple interactions | ISO | Fam177a (Mus musculus) | 6480464 | [bisphenol S co-treated with Tretinoin] results in increased expression of FAM177A mRNA | CTD | PMID:30951980 | FAM177A1 | Human | azoxystrobin | multiple interactions | ISO | Fam177a1 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM177A1 gene | CTD | PMID:33854195 | FAM177A1 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of FAM177A1 exon | CTD | PMID:27901495 | FAM177A1 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of FAM177A1 mRNA | CTD | PMID:22316170 and PMID:26238291 | FAM177A1 | Human | beta-lapachone | increases expression | EXP | | 6480464 | beta-lapachone results in increased expression of FAM177A1 mRNA | CTD | PMID:38218311 | FAM177A1 | Human | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of FAM177A1 protein | CTD | PMID:31163220 | FAM177A1 | Human | bisphenol A | decreases expression | ISO | Fam177a (Mus musculus) | 6480464 | bisphenol A results in decreased expression of FAM177A mRNA | CTD | PMID:30951980 and PMID:33221593 | FAM177A1 | Human | bisphenol F | increases expression | ISO | Fam177a (Mus musculus) | 6480464 | bisphenol F results in increased expression of FAM177A mRNA | CTD | PMID:30951980 | FAM177A1 | Human | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of FAM177A1 mRNA | CTD | PMID:26079696 | FAM177A1 | Human | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of FAM177A1 mRNA | CTD | PMID:38568856 | FAM177A1 | Human | caffeine | increases phosphorylation | EXP | | 6480464 | Caffeine results in increased phosphorylation of FAM177A1 protein | CTD | PMID:35688186 | FAM177A1 | Human | chloropicrin | affects expression | EXP | | 6480464 | chloropicrin affects the expression of FAM177A1 mRNA | CTD | PMID:26352163 | FAM177A1 | Human | chlorpyrifos | multiple interactions | ISO | Fam177a1 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM177A1 gene | CTD | PMID:33854195 | FAM177A1 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of FAM177A1 mRNA | CTD | PMID:19549813 | FAM177A1 | Human | coumarin | increases phosphorylation | EXP | | 6480464 | coumarin results in increased phosphorylation of FAM177A1 protein | CTD | PMID:35688186 | FAM177A1 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of FAM177A1 mRNA | CTD | PMID:37042841 | FAM177A1 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of FAM177A1 protein | CTD | PMID:37730182 | FAM177A1 | Human | glyphosate | multiple interactions | ISO | Fam177a1 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM177A1 gene | CTD | PMID:33854195 | FAM177A1 | Human | imidacloprid | multiple interactions | ISO | Fam177a1 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM177A1 gene | CTD | PMID:33854195 | FAM177A1 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of FAM177A1 protein | CTD | PMID:32959892 | FAM177A1 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of FAM177A1 mRNA | CTD | PMID:23649840 | FAM177A1 | Human | paracetamol | increases expression | ISO | Fam177a1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of FAM177A1 mRNA | CTD | PMID:33387578 | FAM177A1 | Human | paraquat | increases expression | ISO | Fam177a1 (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of FAM177A1 mRNA | CTD | PMID:32680482 | FAM177A1 | Human | phenobarbital | affects expression | ISO | Fam177a (Mus musculus) | 6480464 | Phenobarbital affects the expression of FAM177A mRNA | CTD | PMID:23091169 | FAM177A1 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of FAM177A1 mRNA | CTD | PMID:22714537 | FAM177A1 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of FAM177A1 mRNA | CTD | PMID:21632981 | FAM177A1 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of FAM177A1 mRNA | CTD | PMID:38568856 | FAM177A1 | Human | tetrachloromethane | decreases expression | ISO | Fam177a1 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of FAM177A1 mRNA | CTD | PMID:33387578 | FAM177A1 | Human | thiabendazole | multiple interactions | ISO | Fam177a1 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM177A1 gene | CTD | PMID:33854195 | FAM177A1 | Human | titanium dioxide | decreases expression | ISO | Fam177a (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of FAM177A mRNA | CTD | PMID:29264374 | FAM177A1 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of FAM177A1 mRNA | CTD | PMID:37042841 | FAM177A1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of FAM177A1 mRNA | CTD | PMID:25979313 | FAM177A1 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of FAM177A1 mRNA | CTD | PMID:29154799 | FAM177A1 | Human | valproic acid | affects expression | ISO | Fam177a (Mus musculus) | 6480464 | Valproic Acid affects the expression of FAM177A mRNA | CTD | PMID:17963808 | |